Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $140.40 million. The enterprise value is $202.15 million.
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 73.89 million shares outstanding. The number of shares has increased by 13.13% in one year.
| Current Share Class | 73.89M |
| Shares Outstanding | 73.89M |
| Shares Change (YoY) | +13.13% |
| Shares Change (QoQ) | +2.25% |
| Owned by Insiders (%) | 5.26% |
| Owned by Institutions (%) | 70.71% |
| Float | 58.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 208.79 |
| PS Ratio | 0.46 |
| Forward PS | 0.56 |
| PB Ratio | 1.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.66 |
| P/OCF Ratio | 7.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 234.25, with an EV/FCF ratio of 11.03.
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | 234.25 |
| EV / EBIT | n/a |
| EV / FCF | 11.03 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 1.23.
| Current Ratio | 1.69 |
| Quick Ratio | 1.56 |
| Debt / Equity | 1.23 |
| Debt / EBITDA | 86.32 |
| Debt / FCF | 9.31 |
| Interest Coverage | -1.68 |
Financial Efficiency
Return on equity (ROE) is -103.02% and return on invested capital (ROIC) is -4.17%.
| Return on Equity (ROE) | -103.02% |
| Return on Assets (ROA) | -3.48% |
| Return on Invested Capital (ROIC) | -4.17% |
| Return on Capital Employed (ROCE) | -11.93% |
| Weighted Average Cost of Capital (WACC) | 11.54% |
| Revenue Per Employee | $252,066 |
| Profits Per Employee | -$221,048 |
| Employee Count | 1,200 |
| Asset Turnover | 0.46 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $915,000 in taxes.
| Income Tax | 915,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.60% in the last 52 weeks. The beta is 1.66, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -49.60% |
| 50-Day Moving Average | 1.49 |
| 200-Day Moving Average | 2.10 |
| Relative Strength Index (RSI) | 63.94 |
| Average Volume (20 Days) | 3,249,186 |
Short Selling Information
The latest short interest is 6.35 million, so 8.59% of the outstanding shares have been sold short.
| Short Interest | 6.35M |
| Short Previous Month | 6.59M |
| Short % of Shares Out | 8.59% |
| Short % of Float | 10.81% |
| Short Ratio (days to cover) | 11.25 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $302.48 million and -$265.26 million in losses. Loss per share was -$3.74.
| Revenue | 302.48M |
| Gross Profit | 152.58M |
| Operating Income | -36.33M |
| Pretax Income | -264.34M |
| Net Income | -265.26M |
| EBITDA | 863,000 |
| EBIT | -36.33M |
| Loss Per Share | -$3.74 |
Full Income StatementBalance Sheet
The company has $108.82 million in cash and $170.58 million in debt, giving a net cash position of -$61.76 million or -$0.84 per share.
| Cash & Cash Equivalents | 108.82M |
| Total Debt | 170.58M |
| Net Cash | -61.76M |
| Net Cash Per Share | -$0.84 |
| Equity (Book Value) | 138.15M |
| Book Value Per Share | 1.87 |
| Working Capital | 74.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $18.96 million and capital expenditures -$636,000, giving a free cash flow of $18.33 million.
| Operating Cash Flow | 18.96M |
| Capital Expenditures | -636,000 |
| Depreciation & Amortization | 37.20M |
| Net Borrowing | -232.29M |
| Free Cash Flow | 18.33M |
| FCF Per Share | $0.25 |
Full Cash Flow StatementMargins
Gross margin is 50.44%, with operating and profit margins of -12.01% and -87.69%.
| Gross Margin | 50.44% |
| Operating Margin | -12.01% |
| Pretax Margin | -87.39% |
| Profit Margin | -87.69% |
| EBITDA Margin | 0.29% |
| EBIT Margin | -12.01% |
| FCF Margin | 6.06% |